A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Summary of opinion: Tecentriq,atezolizumab
2019
Case Medical Research
Preserved Fulltext
Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact
doi:10.31525/cmr-a30d19
fatcat:7zsnhlmx2bfo3nhmwbh6s4xmpm